TAG:
myriad genetic
New Market Channel For Esoteric Testing
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab direc…
Another Lab Acquisition: LabCorp To Buy DIANON
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national…
“Direct-to-Consumer” Ad Runs in New York Times
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Two pioneering advertising campaigns launched in September. Both Myriad Genetics and IMPATH targeted consumers with advertisements about diagnostic testing. In each case, the most vocal response to the advertising came from within the medical community. Within the pathology p…
Unfolding Events at Unilab, Specialty Labs and Dynacare
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
RECENT WEEKS BROUGHT important developments to several public lab companies. Each development changes and alters the competitive marketplace for laboratory testing services. It was big news at Specialty Laboratories, Inc. when the troubled lab company signed a Plan of Correction (PO…
Myriad Genetics, LabCorp, Abbott Labs, OraSure,TheraSense
By Robert Michel | From the Volume IX No. 9 – June 24, 2002 Issue
DIRECT-TO-CONSUMER ADS FROM MYRIAD GENETICS TO START THIS FALL FOLLOWING THE EXAMPLE of the pharmaceutical industry in using direct-to consumer advertising to build drug sales, Myriad Genetics, Inc. is about to launch an advertising campaign for its predictive genetics tests…
LabCorp to Help Collect Family DNA Specimens
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: DNA testing will be a primary tool in identifying victims of this major disaster. Officials in New York City are formulating a plan whereby private labs will do DNA testing in conjunction with New York State Police laboratories. Laboratory Corporation of America has been desi…
“August 13, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
In recent years he’s become an influential “behind the scenes” guy within the lab industry. Now Heywood D. Cochrane, Jr. is joining the Board of Directors at AmeriPath, Inc., based in Riviera Beach, Florida. Most laboratorians know Cochrane from his tour as President and CEO of…
Digene, Ivax Diagnostics, Myriad Genetics, Bioscientia, LabOne, Aetna
ROTARY CLUBS LAUNCH MEXICO-BASED CERVICAL SCREENING EFFORT IN MEXICO, Rotary International will attack the problem of cervical cancer among Mexican women by supporting a screening program that utilizes human papillomavirus (HPV) testing. Called “Test for Life,” the prog…
Esoterix, Johnson & Johnson, Medtronic, California Hospitals, Myriad Genetics
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
ESOTERIX, INC. LAUNCHES TEST REPORTS VIA WEB BROWSER WEB-ACCESSED LAB TEST REPORTING is now available at Esoterix, Inc., based in Austin, Texas. The accomplishment represents a major milestone for the lab company. It now has a common lab test reporting capability that draws…
September 8, 1998 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
If any one individual was to be credited with creating the modern commercial laboratory organization, it would be Paul Brown, M.D., founder and former Chairman of MetPath, Inc. (now Quest Diagnostics Incorporated). Where is he now? For ten years, he served as a Direc…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized